跳至主要内容
临床试验/NCT00841178
NCT00841178进行中(未招募)不适用

A Randomised Controlled Trial of the Clinical and Cost Effectiveness of Endovenous Laser Therapy in the Treatment of Varicose Veins Secondary to Isolated Sapheno-Popliteal Incompetence and Short Saphenous Reflux

Hull University Teaching Hospitals NHS Trust2 个研究点 分布在 1 个国家目标入组 106 人开始时间: 2005年10月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
106
试验地点
2
主要终点
Generic Quality of Life - Short Form-36

研究概览

简要总结

Varicose veins are a common problem, affecting up to a third of the western adult population. Most suffer with aching, discomfort, pruritis, and muscle cramps, whilst complications include oedema, eczema, lipodermatosclerosis, ulceration, phlebitis, and bleeding. This is known to have a significant negative effect on patient's quality of life (QoL).

Surgery has been used for many years, but it is known that there is a temporary decline in QoL post-op. This was demonstrated in our pilot study. Surgery leads to painful and prolonged recovery in some patients and has the risks of infection, haematoma and nerve injury.

Recurrence rates are known to be significant. Duplex of veins post surgery has demonstrated persistent reflux in 9-29% of cases at 1 year, 13-40% at 2 years, 40% at 5 years and 60% at 34 years.

26% of NHS patients were 'very dissatisfied' with their varicose vein surgery.

Newer, less invasive treatments are being developed. It would be advantageous to find a treatment that avoided the morbidity of surgery, one that could be performed as a day-case procedure under a local anaesthetic, a treatment that could offer lower recurrence rates and allow an early return to work. These should be the aims of any new treatment for varicose veins.

Endovenous Laser Treatment (EVLT) is performed under a local anaesthetic and uses laser energy delivered into the vein to obliterate it. The vein therefore need not be tied off surgically and stripped out.

The aim of this study is to compare the clinical, cost effectiveness and safety of Surgery and EVLT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary, symptomatic, varicose veins
  • Isolated Sapheno-popliteal (SPJ) incompetence, leading to reflux in the Short saphenous vein (SSV) on duplex ultrasound
  • SSV of 4mm distally
  • Ability to give informed written consent

排除标准

  • Inability to give informed written consent
  • Symptomatic or complicated varicose veins not attributable to SPJ/SSV reflux
  • Evidence of deep venous reflux on duplex scan

结局指标

主要结局

Generic Quality of Life - Short Form-36

时间窗: 1 Week,, 6 Weeks, 3 Months, 1 Year, 2 Years

次要结局

  • Would undergo EVLT again if necessary(1 week, 6 weeks, 3 months, 1 year, 2 years)
  • Cost Effectiveness(2 years)
  • Visual analogue pain scores(1 week)
  • Return to work and normal functioning(1 week, 6 weeks)
  • Disease Specific Quality of Life - Aberdeen Varicose Vein Questionnaire(1 Week, 6 Weeks, 3 Months, 1 Year, 2 Years)
  • Complication rates(1 week, 6 weeks, 3 months, 1 year, 2 years)
  • Duplex assessment(1 week, 6 weeks, 3 months, 1 year, 2 years)
  • Generic quality of life - EuroQol(1 week, 6 weeks, 3 months, 1 year, 2 years)
  • Venous Clinical Severity Score(3 months, 1 year, 2 years)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验